Month: March 2009

FDA Rejects Silenor Insomnia Treatment

The US Food and Drug Administration (FDA) issued a Complete Response Letter to Somaxon Pharmaceuticals, San Diego, for the company’s New Drug Application (NDA) for its insomnia drug Silenor®  (doxepin). After review the FDA determine

Read More

CMS Posts Sleep Testing Final Coverage Policy

The Centers for Medicare and Medicaid Services (CMS) has released the final coverage decision for sleep testing for the diagnosis of obstructive sleep apnea (OSA). The final policy identifies the sleep tests that can be used by a beneficiary&rsq

Read More

Forest, Cypress Delay Launch of Fibromyalgia Drug

Last Updated: 2009-03-06 9:00:16 -0400 (Reuters Health) * Now see mid-2009 launch, delayed from March * Seek "minor" cosmetic change NEW YORK (Reuters) – Forest Laboratories Inc and Cypress Bioscience Inc said on Friday that they

Read More